Market Tracker

05/18 5:15pm ET

Alkermes Plc (NASDAQ:ALKS)

46.27
Delayed Data
As of May 18
 +0.26 / +0.57%
Today’s Change
41.15
Today|||52-Week Range
71.22
-15.46%
Year-to-Date

Today’s Trading

Previous close46.01
Today’s open45.85
Day’s range45.69 - 46.56
Volume792,749
Average volume (3 months)1,172,722
Market cap$7.3B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)+25.36%
Earnings growth (this year)-86.11%
Earnings growth (next 5 years)+45.25%
Revenue growth (last year)+21.15%
P/E ratioNM
Price/Sales9.29
Price/Book6.02

Competitors

 Today’s
change
Today’s
% change
ALNYAlnylam Pharmaceutic...+1.17+1.15%
SGENSeattle Genetics Inc-0.56-0.98%
TSROTESARO Inc-2.87-5.67%
IONSIonis Pharmaceutical...+0.81+1.85%
Data as of 4:00pm ET, 05/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.08
Annual revenue (last year)$903.4M
Annual profit (last year)-$157.9M
Net profit margin-17.48%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President &
Chief Operating Officer
James Robinson
Corporate headquarters
Dublin, Dublin

Forecasts